SARS-CoV-2 Pneumonia Clinical Trial
Official title:
Predictors of Respiratory Failure Requiring ICU Admission Among Hospitalized Patients With SARS-Cov-2 Infection
The emergence of SARS-CoV-2 is currently engaging and consuming most of resources of
efficient healthcare systems in Europe, and several hospitals are currently experiencing a
shortage of ICU beds for critically-ill patients with SARS-CoV-2 pneumonia.
A risk stratification based on clinical, radiological and laboratory parameters seems
necessary in order to better identify those patients who may need ICU admission and/or those
who may benefit from a prompt antiviral therapy
The study will compared patients with and without respiratory failure in order to find risk factors for need for ICU admission. A simple score based on risk factors will be created from a multicenter Italian cohort and validated in a multicenter international cohort. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04382625 -
Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial
|
Phase 4 | |
| Enrolling by invitation |
NCT04602442 -
Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia
|
Phase 2 | |
| Recruiting |
NCT05773001 -
Macrophage Regulation of Ozone-Induced Lung Inflammation
|
Phase 1 | |
| Recruiting |
NCT04605757 -
Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study
|
||
| Not yet recruiting |
NCT04405921 -
Hydroxychloroquine, Azithromycin in the Treatment of Covid-19
|
Phase 3 | |
| Completed |
NCT05465785 -
A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)
|
N/A | |
| Completed |
NCT04491240 -
Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.
|
Phase 1/Phase 2 |